Sacituzumab govitEcan in THYroid Cancers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alejandro García-Alvarez, M.D.; Ph.D.
Hospital Universitario Vall d´Hebron
Study Chair - Jaume Capdevila, M.D.; Ph.D.
Hospital Universitario Vall d´Hebron
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitari Vall D'hebron
Barcelona, Spain
A Principal Investigator Designated by the sponsor, M.D.; Ph.D.Recruiting - Complexo Hospitalario Universitario de Ferrol
Ferrol, Spain
A Principal Investigator Designated by the sponsor, M.D.; Ph.D.Not, yet, recruiting - Institut Catala D´oncologia (ico) -Hospitalet
Hospitalet de Llobregat (Barcelona), Spain
A Principal Investigator Designated by the sponsor, M.D.; Ph.D.Recruiting - Hospital Clínico San Carlos
Madrid, Spain
A Principal Investigator Desingated by the sponsor, M.D.; Ph.D.Recruiting - Hospital Universitario Ramón Y Cajal
Madrid, Spain
A Principal Investigator Designated by the sponsor, M.D.; Ph.D.Not, yet, recruiting - Hospital Universitario la Paz
Madrid, Spain
A Principal Investigator Designated by the sponsor, M.D.; Ph.D.Recruiting - Md Anderson Cancer Center Madrid
Madrid, Spain
A principal investigator Designated by the sponsor, M.D.; Ph.D.Recruiting - Hospital General Universitario Morales Meseguer
Murcia, Spain
A Principal Investigator Designated by the sponsor, M.D.; Ph.D.Recruiting - Hospital Universitario Central de Asturias
Oviedo, Spain
A Principal Investigator Designated by the sponsor, M.D.; Ph.D.Recruiting - H.U. Marqués de Valdecilla
Santander, Spain
A Principal Investigator Designated by the sponsor, M.D.; Ph.D.Recruiting - Hospital Universitario Miguel Servet
Zaragoza, Spain
A Principal Investigator Designated by the sponsor, M.D.; Ph.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Sept 2024
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2027
- Last update posted
- 1 Nov 2024
- Registered enrollment
- 42
- Registry id
- NCT06235216
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.